Compare ATAI & LPAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATAI | LPAA |
|---|---|---|
| Founded | 2018 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 299.3M |
| IPO Year | 2021 | N/A |
| Metric | ATAI | LPAA |
|---|---|---|
| Price | $3.66 | $10.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $15.57 | N/A |
| AVG Volume (30 Days) | ★ 4.6M | 871.0 |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $308,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $285.00 | N/A |
| P/E Ratio | ★ N/A | $31.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $10.18 |
| 52 Week High | $6.73 | $10.74 |
| Indicator | ATAI | LPAA |
|---|---|---|
| Relative Strength Index (RSI) | 46.06 | 57.92 |
| Support Level | $3.41 | $10.40 |
| Resistance Level | $4.32 | N/A |
| Average True Range (ATR) | 0.25 | 0.01 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 27.82 | 75.00 |
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
Launch One Acquisition Corp is a blank check company.